Skip to the page

Data / Form D filings / Zyus Life Sciences Corp

Zyus Life Sciences Corp: Form D filings

Zyus Life Sciences Corp, a health care company in Saskatoon, Saskatchewan, Canada, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on August 13, 2025, reports $72,768 sold of a $726,198 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
407 DOWNEY ROAD, SUITE 204, Saskatoon, Saskatchewan, Canada, S7N 4
Phone
(306) 242-2357
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Ontario, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2036745

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 13, 2025New notice$726,198$72,768$653,4301Jul 29, 2025sec.gov
May 14, 2025New notice$1,434,600$573,840$860,7606May 6, 2025sec.gov
Sep 10, 2024New notice$117,695$117,6952Aug 26, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John KnowlesDirector
Brett ZettlExecutive Officer, Director
Keith CarpenterExecutive Officer
Garnette WeberDirector
Wayne BrownleeDirector
Richard HoytDirector
Dr. Julie StakiwExecutive Officer
Dr. Charlotte Moore HepburnDirector
John HyshkaExecutive Officer

Every Form D from the week of Aug 11, 2025 · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Zyus Life Sciences Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.